Scopus Asset Management’s AB InBev BUD Stock Holding History

Scopus Asset Management’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-250,000	Closed	-$14.2M	–	204
2023 Q2	$14.2M	Buy	+250,000	New	+$15.1M	0.4%	99
2021 Q3	–	Sell	-500,000	Closed	-$36M	–	358
2021 Q2	$36M	Buy	+500,000	New	+$36.5M	0.47%	65

Other funds holding BUD

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Scopus Asset Management's BUD Position: Q3 2023 in Review

Scopus Asset Management sold out of AB InBev (BUD) in Q3 2023, closing a stake of 250,000 shares — an estimated $14.2M sold.

Scopus Asset Management first reported a position in BUD in Q3 2013 and held it in 10 quarters. The position peaked at $103M in Q2 2021. 478 funds tracked by Wall St. Rank hold BUD as of Q3 2023.

Scopus Asset Management reported no remaining AB InBev position as of Q3 2023 after selling out during the quarter.
Scopus Asset Management sold 250,000 AB InBev shares in Q3 2023, an estimated $14.2M.
Scopus Asset Management first reported a position in AB InBev in Q3 2013 and held it in 10 quarters.
Scopus Asset Management's AB InBev position peaked at $103M in Q2 2021.
478 funds tracked by Wall St. Rank held AB InBev as of Q3 2023.

Based on Scopus Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.